Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARDOX: ThermoDox and focused ultrasound for liver tumors
NCT02181075Phase 1Completed
- Sponsor
- University of Oxford
- Start
- Jul 2014
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Phase 1, open-label trial of doxorubicin in Liver tumor (LT) (2 arms), sponsored by University of Oxford. Primary endpoints: Concentration of Total Intratumoral Doxorubicin in Liver Tumour at Day 1 and Patients Demonstrating >Two-fold Increase in the Amount of Intratumoural Doxorubicin at Day 1. Started Jul 2014; status: completed.
02
Drugs
doxorubicin
03
Conditions
Liver tumor (LT)
Beyond the preview
Go deeper on NCT02181075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02181075.